Company Filing History:
Years Active: 2025
Title: The Innovations of Alessandro Bonifazi
Introduction
Alessandro Bonifazi is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmacology, particularly in the development of novel compounds that target dopamine receptors. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.
Latest Patents
Alessandro Bonifazi holds a patent for "D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof." This patent discloses novel compounds, including dopamine D3 receptor agonists, along with their compositions, methods of use, and processes for synthesizing these compounds. The patent emphasizes the development of D3 selective agonist compounds, specifically bitopic ligands that incorporate chirality.
Career Highlights
Bonifazi is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization highlights his commitment to advancing health-related innovations. With a focus on drug development, he has contributed to the understanding and application of receptor-targeted therapies.
Collaborations
Alessandro Bonifazi has collaborated with Francisco Oscar Battiti, further enhancing the scope and impact of his research. Their partnership exemplifies the importance of teamwork in the pursuit of scientific advancements.
Conclusion
Alessandro Bonifazi's contributions to the field of pharmacology through his innovative patents and collaborations demonstrate his dedication to improving health outcomes. His work continues to inspire future research and development in receptor-targeted therapies.